🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-23
Trial ID
NCT02723955
The purpose of this trial is to investigate the efficacy of cetuximab in co...
Status
Completed
Location
Research Site
Start Date
2004-12
Trial ID
NCT00122460
The aim of the study is to assess if gemcitabine in combination with carbop...
Status
Completed
Location
Loh Guan Lye Specialist Centre
Start Date
2008-01
Trial ID
NCT00697905
Treatments Being Tested
Study to evaluate the efficacy of treatment by radiotherapy and pembrolizum...
Status
Recruiting
Location
Institut Sainte Catherine
Start Date
2021-12-01
Trial ID
NCT04747054
Treatments Being Tested
This was an open-label, nonrandomized, Phase 1/2 study designed to determin...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2017-05-02
Trial ID
NCT03085914
The purpose of this study is to evaluate the safety, feasibility and outcom...
Status
Recruiting
Location
N.N. Blokhin National Medical Research Center of Oncology
Start Date
2022-09-14
Trial ID
NCT05547529
The purpose of this randomized study is to clarify if neoadjuvant radiochem...
Status
Completed
Location
Upper Digestive Diseases. Department of surgery, Karolinska University Hospital
Start Date
2006-10
Trial ID
NCT01362127
Treatments Being Tested
The primary objective of the study is to determine the maximum tolerated do...
Status
Completed
Location
Alabama Oncology
Start Date
2013-03-29
Trial ID
NCT01803282
The purpose of this study is to test whether the use of advanced radiation ...
Status
Completed
Location
University of Michigan
Start Date
2003-08
Trial ID
NCT00580983
Treatments Being Tested
This study is designed as Phase II/III. Phase II is aimed to evaluate safet...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2019-06-19
Trial ID
NCT03992911
Treatments Being Tested